Chabbert-Buffet N

No ORCID on file · 36 papers in corpus
lab-animal 2016
Hormones & cancer ·doi:10.1007/s12672-016-0255-4

Breast cancer is a hormone-dependent disease in which estrogen signaling targeting drugs fail in about 10 % due to resistance. Strong evidences highlighted the mitogen role of progesterone, its ligands, and the corresponding progesterone re…

review 2016
Minerva ginecologica

Deep infiltrating endometriosis (DIE) affects several anatomical locations including the bladder, torus uterinum, uterosacral ligament, rectovaginal septum and bowel. It is the most debilitating form of endometriosis and causes severe pain,…

lab-animal 2014
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-014-0390-1

PURPOSE: To assess the impact of peritoneal endometriosis on oocyte and embryo quality in a mouse model. METHODS: Peritoneal endometriosis was surgically induced in 33 B6CBA/F1 female mice (endometriosis group, N = 17) and sham-operated we…

lab-animal 2014
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2014.10.038

OBJECTIVE: Pregnancy is known to alleviate the symptoms of endometriosis and is also known to be a pro-angiogenic condition affecting blood and lymphatic vessels. However, angiogenesis actively participates in the development of endometrios…

review 2013
Journal de gynecologie, obstetrique et biologie de la reproduction ·doi:10.1016/j.jgyn.2013.09.032

Medical treatment of functional cysts and endometriomas, and the risk of developing functional ovarian cysts in different therapeutic situations are assessed. The available literature regarding the treatment of functional cysts is limited b…

review 2012
Molecular and cellular endocrinology ·doi:10.1016/j.mce.2012.02.021

Selective progesterone receptor modulators (SPRMs) have been developed since the late 70s when mifepristone was first described. They act through nuclear progesterone receptors and can have agonist or mixed agonist antagonist actions depend…

review 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.08.021

OBJECTIVE: To discuss the mechanism of action of selective progesterone receptor modulators (SPRMs) and summarize the preclinical and clinical efficacy and safety data supporting the potential use of these compounds for gynecologic indicati…

review 2008
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625180802267060

Currently developed progesterone receptor modulators (PRMs) are steroid-derived compounds with mild or potent antiprogestin activity. PRMs may exert a contraceptive activity by different mechanisms such as blockade of ovulation and endometr…

review 2008
Women's health (London, England) ·doi:10.2217/17455057.4.3.269

Progesterone-receptor modulators (PRMs) are progesterone-receptor ligands that can exert agonistic, antagonistic or mixed agonist-antagonist effects depending on the cellular context. The mechanisms of action of these compounds are still in…

other 2008
Bulletin de l'Academie nationale de medecine ·doi:10.1016/s0001-4079(19)32715-3

Progesterone antagonists belong to the family of selective progesterone receptor modulators. SPRMs already have several applications in women's health. Their main value lies in their effect on endometrium. For example, they can be used to r…

review 2005
Human Reproduction Update ·doi:10.1093/humupd/dmi002

Since the discovery of the antiprogestin mifepristone, hundreds of similar compounds have been synthesized, which can be grouped in a large family of progesterone receptor ligands. This family includes pure agonists such as progesterone its…